Is Gene Therapy a False Trail for Precision Medicine Research?

August 23, 2016

(Health IT Analytics) – Gene therapy researchers aiming to create precision medicine treatments may be heading in the wrong direction, according to an editorial published last month in the Journal of the American Medical Association, and should not be the only areas of study to receive large amounts of funding from organizations like the National Institutes of Health (NIH). Major research organizations with millions of dollars to spend should cast a wider net when choosing which studies to fund, and should trade an emphasis on immediate, concrete results for a more open approach that allows for the exploration of additional scientific theories.